Healthcare Company KenSci Raises $22 Million in Series B Funding

KenSci, a healthcare risk prediction platform utilizing machine learning and artificial intelligence, closed $22 million in a Series B funding round led by Polaris Partners which included existing investors Ignition Partners, Osage University Partners, and Mindset Ventures. UL Ventures joined the round as a strategic investor, offering global reach and compliance expertise.

Founded by Prof. Ankur Teredesai, from the University of Washington Tacoma, and Samir Manjure, a longtime Microsoft executive, KenSci’s risk prediction platform is designed to help health systems across the globe improve the quality of care they provide at lower costs. Built on Azure ML, SQL, and providing insights using Power BI, the platform ingests EMR, claims, billings, pharmacy, wearable, and psychosocial data to identify patterns that help uncover opportunities to save costs and lives.

The company plans to use the funds to overcome challenges in utilization, variation, and hospital operations with data-led predictive insights, and further accelerate KenSci’s product roadmap and global expansion.